Home page  |  Help  |  Clear
English  |  French
 Search  |  Categories  |  Titles A-Z  |  Countries  |  Compare countries  |  Index  
Full TOC
Expand Document
Expand Chapter
Preferences

close this bookStandard Treatment Guidelines (STG) and The National Essential Drug List for Tanzania (NEDLIT) (WHO; 1997; 210 pages)
View the documentFOREWORD
View the documentACKNOWLEDGMENTS
View the documentINTRODUCTION
close this folderStandard Treatment Guidelines (STG)
Open this folder and view contents1. GASTROINTESTINAL CONDITIONS
Open this folder and view contents2. RESPIRATORY DISEASES
Open this folder and view contents3. OBSTETRIC AND GYNAECOLOGICAL CONDITIONS AND CONTRACEPTION
Open this folder and view contents4. CARDIOVASCULAR DISEASES
Open this folder and view contents5. MALARIA
Open this folder and view contents6. SKIN DISEASES
Open this folder and view contents7. SEXUALLY TRANSMITTED INFECTIONS / DISEASES (STD)
Open this folder and view contents8. DENTAL AND ORAL CONDITIONS
close this folder9. GENITO-URINARY DISEASES: KIDNEY CONDITIONS
View the document9.1 Glomerulonephritis
View the document9.2 Pyelonephritis
View the document9.3 Nephrotic Syndrome
Open this folder and view contents10. EAR, NOSE AND THROAT CONDITIONS
Open this folder and view contents11. EYE CONDITIONS
Open this folder and view contents12. TUBERCULOSIS AND LEPROSY
Open this folder and view contents13. MUSCULOSKELETAL CONDITIONS AND JOINT DISEASES
Open this folder and view contents14. METABOLIC AND ENDOCRINE SYSTEM CONDITIONS
Open this folder and view contents15. CENTRAL NERVOUS SYSTEM DISEASE CONDITIONS
Open this folder and view contents16. OTHER DISEASE CONDITIONS
Open this folder and view contents17. VIRAL INFECTIONS
Open this folder and view contents18. ALLERGIC REACTIONS
Open this folder and view contents19. NUTRITIONAL AND HAEMATOLOGIC CONDITIONS
Open this folder and view contents20. MALIGNANT DISEASE CONDITIONS
Open this folder and view contents21. INJURIES AND TRAUMA
View the document22. FOREIGN BODIES
View the document23. PAIN
View the document24. POISONING
View the document25. NORMAL LABORATORY VALUES
Open this folder and view contentsNATIONAL ESSENTIAL DRUG LIST
View the documentABBREVIATIONS AND SYMBOLS
 

9.3 Nephrotic Syndrome

Clinical features: It is a syndrome comprising of proteinuria (> 3 g/24 hours), hypoalbuminemia (< 30 g/litre) and oedema. Nephrotic Syndrome may be due to primary glomerular disease or secondary to other diseases including infections.

Treatment guidelines

• Treat underlying cause where applicable
• Allow bed rest
• Give high protein diet
• Encourage consumption of potassium rich foods e.g bananas, papaws, potatoes and pigeonpeas.
• Restrict salt and water intake
• Try and induce diuresis


Drug of choice

Frusemide

 

40 - 200 mg every 12 hours.

Adult

Measure urea and electrolytes. Restrict fluid to 1 litre daily until diuresis is achieved. In case oedemas gross and no response is observed you may consider adding.

 

Prednisolone

 

40 - 60 mg once daily. Tail off the dose over 6 - 8 weeks to avoid a relapse.

Anticoagulant if immobile

Heparin 5000 units three times a day.


Search for underlying cause - exclude SLE.

Children

Follow similar schedule with the following dosage

Frusemide 1 mg/kg body weight every 24 hours

Prednisolone 1 mg/kg body weight daily for 6-8 weeks, tail the dose to avoid relapse.

Heparin 15-25 units/kg body weight by IV

OR


250 units/kg body weight subcutaneous inj. every 12 hours.

to previous sectionto next section

Please provide your feedback
Abbreviations
English  |  French